- Home
- VTSI vs ANL Comparison
VTSI vs ANL Comparison
Compare VTSI & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- ANL
- Stock Information
- Founded
- VTSI 1993
- ANL 2004
- Country
- VTSI United States
- ANL Cayman Islands
- Employees
- VTSI N/A
- ANL N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- ANL
- Sector
- VTSI Consumer Discretionary
- ANL
- Exchange
- VTSI Nasdaq
- ANL Nasdaq
- Market Cap
- VTSI 60.6M
- ANL 61.8M
- IPO Year
- VTSI N/A
- ANL 2023
- Fundamental
- Price
- VTSI $5.83
- ANL $1.75
- Analyst Decision
- VTSI Strong Buy
- ANL Hold
- Analyst Count
- VTSI 1
- ANL 1
- Target Price
- VTSI $7.00
- ANL N/A
- AVG Volume (30 Days)
- VTSI 77.8K
- ANL 9.7K
- Earning Date
- VTSI 08-11-2025
- ANL 09-19-2025
- Dividend Yield
- VTSI N/A
- ANL N/A
- EPS Growth
- VTSI N/A
- ANL N/A
- EPS
- VTSI 0.10
- ANL N/A
- Revenue
- VTSI $27,068,543.00
- ANL N/A
- Revenue This Year
- VTSI $10.31
- ANL N/A
- Revenue Next Year
- VTSI $12.71
- ANL N/A
- P/E Ratio
- VTSI $58.35
- ANL N/A
- Revenue Growth
- VTSI N/A
- ANL N/A
- 52 Week Low
- VTSI $3.57
- ANL $1.10
- 52 Week High
- VTSI $8.53
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- VTSI 45.93
- ANL 59.23
- Support Level
- VTSI $5.67
- ANL $1.62
- Resistance Level
- VTSI $6.08
- ANL $1.85
- Average True Range (ATR)
- VTSI 0.25
- ANL 0.10
- MACD
- VTSI 0.02
- ANL 0.01
- Stochastic Oscillator
- VTSI 64.47
- ANL 65.79
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.